ALCYOMICS LTD - United Kingdom 

Ranking results:

Past rankings:

2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2015 0 4.038.972 273.288 1
2012 0 3.226.319 250.652 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
UNIVERSITY OF NEWCASTLE UPON TYNE2
ACREO AB1
CHR HANSEN1
DANMARKS TEKNISKE UNIVERSITET1
FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED1
KLINIKUM DER UNIVERSITAET REGENSBURG1
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN1
LINKOEPING UNIVERSITY1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MEDIZINISCHE UNIVERSITAET WIEN1
MILTENYI BIOTEC1
MULTIMMUNE1
SANOFIAVENTIS DEUTSCHLAND1
TECHNISCHE UNIVERSITAT BERLIN1
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS1
UNIVERSITY OF OSLO1
UNIVERZITA KARLOVA1

Constancy:

Total number of partners: 18
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 18
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2015-01-01Rapid Bioprocess Development Biorapidparticipant4.038.9729
2012-10-01Improving HSCT By Validation Of Biomarkers & Development Of Novel Cellular Therapies CELLEUROPEparticipant3.226.31911